HDAC8 and STAT3 repress BMF gene activity in colon cancer cells

Y Kang1, H Nian2, P Rajendran3

  • 1Linus Pauling Institute, Oregon State University, Corvallis, OR, USA.

Cell Death & Disease
|October 17, 2014
PubMed

Insights

A novel seleno-α-keto acid triggers cancer cell death by reactivating the Bcl-2-modifying factor (Bmf) gene. This approach bypasses resistance mechanisms and offers a new strategy for developing targeted cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Histone deacetylase (HDAC) inhibitors show promise as anticancer agents but can face resistance.
  • Resistance is often linked to anti-apoptotic Bcl-2 functions, specifically BH3-only protein silencing.
  • Reactivating BH3-only proteins offers a potential strategy to overcome HDAC inhibitor resistance.

Purpose of the Study:

  • To investigate a novel seleno-α-keto acid as an anticancer agent.
  • To explore its mechanism of action, focusing on histone acetylation and apoptosis induction.
  • To identify specific molecular targets and pathways involved in its therapeutic effect.

Main Methods:

  • Treatment of human colon cancer cells with a novel seleno-α-keto acid.
  • Assessment of global histone acetylation and apoptosis.
  • Profiling of survival factors and analysis of the Bcl-2-modifying factor (Bmf) gene promoter.
  • Investigation of transcription factors (STAT3, Sp3) and coactivators (p300) using inhibitors and RNA interference.

Main Results:

  • The seleno-α-keto acid induced global histone acetylation and p21-independent apoptosis in colon cancer cells.
  • Bcl-2-modifying factor (Bmf) was identified as a critical BH3-only member involved in the apoptotic response.
  • HDAC8 was found to directly repress BMF gene expression by interacting with STAT3/Sp3 and p300 on the BMF promoter.
  • The repressive function of HDAC8 on BMF could be dissociated from HDAC1, enabling Bmf-mediated apoptosis.

Conclusions:

  • This study identifies BMF as a direct target gene repressed by HDAC8.
  • HDAC8-selective inhibitors could be a promising therapeutic strategy for cancer, potentially uncoupling repression from HDAC1.
  • The findings offer new insights into overcoming resistance to HDAC inhibitors and developing targeted anticancer treatments.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.7K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.0K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
6.8K